Posts Tagged ‘neuropsychiatric’
Report: 35% of worldwide dementia cases could be prevented by modifying these 9 modifiable risk factors
The Lancet Commission: One Third of Dementia May Be Preventable (Lancet report release): “Today’s findings are extremely hopeful,” said Maria Carrillo, PhD, chief science officer at the Alzheimer’s Association. “At an individual level, many people have the potential to reduce their risk of cognitive decline, and perhaps dementia, through simple, healthful behavior changes. At a…
Read MoreE‑Newsletter: Neuroimaging + machine learning can predict, with 96% accuracy, whether high-risk 6‑month-old babies will develop autism spectrum disorder (ASD) by age 2
_____ Time for SharpBrains’ June e‑newsletter, featuring fascinating scientific findings, promising assessments, therapies and brain health monitoring tools…and some fun optical illusions :-) New research Study combines neuroimaging with machine learning to predict, with 96% accuracy, whether high-risk 6‑month-old babies will develop autism spectrum disorder (ASD) by age 2 Cognitive Training or Gingko Biloba to prevent cognitive decline and…
Read MoreMental health meets the digital revolution: Mindstrong Health raises $14 million to modernize the diagnosis and treatment of neuropsychiatric disorders via artificial intelligence (AI) and smartphones
— Mindstrong Health Raises $14 Million in Series‑A Funding (press release): “Mindstrong Health, a startup transforming the diagnosis and treatment of neuropsychiatric disorders through the power of AI and ubiquitous mobile technology, today announced that it has secured a $14 million round of Series‑A funding. Led by Foresite Capital and ARCH Venture Partners, the round…
Read MoreIBM ranked #14 Holder of Pervasive Neurotech Intellectual Property*
International Business Machines (IBM) is a multinational technology company and consultancy. Their product areas range from computer hardware and software to infrastructure, hosting, mainframe, and a range of services.
Read MoreGrowing awareness of the opportunities and risks posed by pharmacological cognitive enhancement (aka “smart drugs”)
. More research needed on use of ‘smart drugs’ by healthy people (Medical News): “Drugs such as methylphenidate and modafinil, marketed as Ritalin and Provigil respectively, are used by some healthy individuals in order to boost their cognitive performance, despite a general lack of knowledge about
Read MoreBrain Failure and Brain Fitness: A Farewell to Dementia?
A dreaded diagnosis, that dimmed and dooming dilemma. Feared, sometimes fought, too often forgotten. It is the grayest, ghastliest elephant in the room: dementia. What is dementia? I, like many others who dedicate their professional efforts to its study and treatment, have no good answer. I believe we are lost in our lexicon, trying to…
Read More